Pathogenic BRCA1 Mutations Disrupt Allosteric Control by BARD1
The Journal of Physical Chemistry B · 2025
DOI: 10.1021/acs.jpcb.5c03653 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2025. Verfasst von Ayan Bhattacharjee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Biochemistry & Biophysics and Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: BRCA1 Protein, Ubiquitin-Protein Ligases, Tumor Suppressor Proteins. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Foundation for the National Institutes of Health, Basser Center of BRCA.
Abstract (Originalsprache)
Mechanistic insight into biophysical perturbations caused by pathogenic missense mutations is highly valuable information for the rational design of therapeutics. For hereditary breast and ovarian cancers, multiple pathogenic mutations in the N-terminal domain of BRCA1 have been reported in patients. How exactly these mutations disrupt the catalytic activity of BRCA1, and thereby lead to oncogenesis, is unknown. Here, we posit that the mechanism of pathogenesis is tied to how binding of BARD1 activates BRCA1 for E3 ligase activity. We use atomistic molecular dynamics simulations and Markov state modeling to uncover how BARD1 selects for the active conformational states of BRCA1. We show that the helix bundle, where BARD1 binds, is allosterically coupled to the E2 interface. Furthermore, we show that BARD1 selects for conformational states that are preorganized for E3 activity. Lastly, we show that pathogenic mutations allosterically destabilize active states, whereas hyperactive mutations constitutively increase their likelihood. These results provide a concrete strategy supported by mechanistic insight for the design of restorative small molecules targeting BRCA1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Biochemistry & Biophysics and Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
ORCID-Profile: Ayan Bhattacharjee, Gregory R Bowman
Förderung
- NIGMS NIH HHS
- Foundation for the National Institutes of Health
- Basser Center of BRCA
Zitieren
APA
Bhattacharjee, A., & Bowman, G. R. (2025). Pathogenic BRCA1 Mutations Disrupt Allosteric Control by BARD1. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.5c03653
Vancouver
Bhattacharjee A, Bowman GR. Pathogenic BRCA1 Mutations Disrupt Allosteric Control by BARD1. The Journal of Physical Chemistry B. 2025. doi:10.1021/acs.jpcb.5c03653
BibTeX
@article{Bhattacharjee2025,
author = {Bhattacharjee, Ayan and Bowman, Gregory R},
title = {Pathogenic BRCA1 Mutations Disrupt Allosteric Control by BARD1},
journal = {The Journal of Physical Chemistry B},
year = {2025},
doi = {10.1021/acs.jpcb.5c03653}
}
EUVIMED